Fecal Transplant for Gut Symptoms in Extrapulmonary Neuroendocrine Cancer
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests whether fecal microbiota transplantation (FMT) – transferring healthy gut bacteria via capsules – can help prevent or ease digestive side effects (like diarrhea or constipation) caused by cancer treatment for extrapulmonary neuroendocrine neoplasms. If you are experiencing such symptoms, this approach might improve your quality of life during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a diagnosis of extrapulmonary neuroendocrine neoplasm (a rare tumor outside the lungs).
- You developed digestive issues (such as diarrhea, constipation, vomiting, or nausea) during the first three cycles of standard cancer treatment.
- You can swallow capsules whole without chewing.
- You have not taken broad-spectrum antibiotics (oral or IV) in the past 3 days.
- Your doctor expects you to live at least 3 more months and you are willing to sign a consent form and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
This trial tests a treatment called “washed microbiota transplant,” which transfers healthy gut bacteria to help relieve intestinal problems that started after cancer therapy. You might benefit if you’re an adult with certain ongoing stomach or bowel symptoms after standard cancer treatment, and your body is stable enough for the procedure.
This trial tests whether fecal transplants (putting healthy donor bacteria into your gut) can help with side effects like diarrhea, constipation, or nausea caused by cancer treatments. It is for people with advanced gastrointestinal cancer who are about to start their fourth round of chemo or targeted therapy.
This trial tests whether transferring healthy gut bacteria from a donor can help patients with advanced cancer regain weight and strength. Cancer cachexia—extreme weight loss from cancer—is treated by restoring the gut's natural bacteria balance.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial tests whether transplanting healthy donor bacteria (fecal microbiota) into the gut can help adults with blood cancers who have stubborn infections, C. diff, or complications after stem cell transplant. It may reduce dangerous germs and improve gut health.
Hear when a new Treatment-related Gastrointestinal Toxicity (Including Diarrhea, Constipation, Nausea, and Vomiting) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.